Fintel reports that on October 30, 2025, Cantor Fitzgerald maintained coverage of CVS Health (NYSE:CVS) with a Overweight recommendation. Analyst Price Forecast Suggests 12.77% Upside As of October 30 ...
Hosted on MSN
CVS Health (NYSE:CVS) Delivers Strong Q3 Numbers
Diversified healthcare company CVS Health (NYSE:CVS) reported in Q3 CY2025, with sales up 7.8% year on year to $102.9 billion. Its non-GAAP profit of $1.60 per share was 17.9% above analysts’ ...
CVS Health Corp. is a health solutions company, which engages in the provision of healthcare services. It operates through the following segments: Health Care Benefits, Health Services, Pharmacy and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback